糖尿病骨代谢异常与脂肪组织的关系(5)
[24] Benayahu D，Shur I，Ben-Eliyahu S.Hormonal changes affect the bone and bone and bone marrow cells in a rat model[J].Journal of Cellular Biochemistry，2000，79(3)：407-415.
[25] Napoli N，Vattikuti S，Yarramaneni J，et al.Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women[J].Maturitas，2012，72(1)：66-71.
[26] Manolagas S C.From estrogen-centric to aging and oxidative stress：a revised perspective of the pathogenesis of osteoporosis[J].Endocrine Reviews，2010，31(3)：266-300.
[27] Michael H，Harkonen P L，Vaananen H K，et al.Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption[J].Journal of Bone and Mineral Research，2005，20(12)：2224-2232.
[28] Cornish J，Naot D.Amylin and adrenomedullin：novel regulators of bone growth[J].Curr Pharm Des，2002，8(23)：2009-2021.
[29] Gutierrez-Rojas I，Lozano D，Nuche-Berenguer B，et al.
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status[J].Mol Cell Endocrinol，2013，365(2)：309-315.
(收稿日期：2019-10-17) (本文編辑：董悦)
通信作者：赵冬琴, 百拇医药(赵冬琴 邬月琴)
[25] Napoli N，Vattikuti S，Yarramaneni J，et al.Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women[J].Maturitas，2012，72(1)：66-71.
[26] Manolagas S C.From estrogen-centric to aging and oxidative stress：a revised perspective of the pathogenesis of osteoporosis[J].Endocrine Reviews，2010，31(3)：266-300.
[27] Michael H，Harkonen P L，Vaananen H K，et al.Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption[J].Journal of Bone and Mineral Research，2005，20(12)：2224-2232.
[28] Cornish J，Naot D.Amylin and adrenomedullin：novel regulators of bone growth[J].Curr Pharm Des，2002，8(23)：2009-2021.
[29] Gutierrez-Rojas I，Lozano D，Nuche-Berenguer B，et al.
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status[J].Mol Cell Endocrinol，2013，365(2)：309-315.
(收稿日期：2019-10-17) (本文編辑：董悦)
通信作者：赵冬琴, 百拇医药(赵冬琴 邬月琴)